Anyfantakis Anastasios, Anyfantakis Dimitrios, Vourliotaki Irene
Department of Endocrinology, Venizeleio General Hospital, Heraklion, Crete, Greece.
Primary Health Care Centre of Kissamos, Chania, Crete, Greece.
Case Rep Endocrinol. 2016;2016:7546453. doi: 10.1155/2016/7546453. Epub 2016 Sep 28.
Resistance to thyroid hormone (RTH) is an extremely rare dominantly inherited condition of impaired tissue responsiveness to thyroid hormone (TH). Most patients with RTH have mutations in the gene that encodes the isoform of the receptor of thyroid hormone ( gene). Mutant receptors are unable to activate or repress target genes. The majority of them are asymptomatic or rarely have hypo- or hyperthyroidism. RTH is suspected by the finding of persistent elevation of serum levels of free T3 (FT3) and free T4 (FT4) and nonsuppressed TSH. We present two cases of RTH diagnosed after total thyroidectomy. The first patient was initially diagnosed with primary hyperthyroidism due to toxic multinodular goiter. The second patient had undergone thyroidectomy for multinodular goiter 16 years before diagnosis of RTH. After thyroidectomy, although on relatively high doses of levothyroxine, both of them presented with the laboratory findings of RTH. Genetic analysis revealed RTH.
甲状腺激素抵抗(RTH)是一种极为罕见的常染色体显性遗传性疾病,其特征为组织对甲状腺激素(TH)的反应性受损。大多数RTH患者的甲状腺激素受体( 基因)编码亚型的基因发生突变。突变受体无法激活或抑制靶基因。大多数患者无症状,或很少出现甲状腺功能减退或亢进。通过发现血清游离T3(FT3)和游离T4(FT4)水平持续升高以及促甲状腺激素(TSH)未被抑制而怀疑RTH。我们报告两例在全甲状腺切除术后诊断为RTH的病例。首例患者最初因毒性多结节性甲状腺肿被诊断为原发性甲状腺功能亢进。第二例患者在被诊断为RTH的16年前因多结节性甲状腺肿接受了甲状腺切除术。甲状腺切除术后,尽管服用了相对高剂量的左甲状腺素,但两人均表现出RTH的实验室检查结果。基因分析确诊为RTH。